Brammer Bio is a viral vector contract development and manufacturing organization for companies developing gene-modified cell therapies and in vivo gene therapies. It delivers a range of services, including the clinical and commercial supply of viral vectors for in vivo gene and ex vivo modified-cell based therapies, process and analytical development, regulatory support, etc.